Research advances in the role of inflammatory response and related treatment strategies in acute-on-chronic liver failure
10.3969/j.issn.1001-5256.2022.08.041
- VernacularTitle:炎症反应在慢加急性肝衰竭中的作用及治疗策略
- Author:
Huaqian XU
1
,
2
;
Xue LI
1
,
2
;
Shanhong TANG
1
,
2
Author Information
1. School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China
2. Department of Gastroenterology, The General Hospital of Western Theater Command, Chengdu 610083, China
- Publication Type:Reviews
- Keywords:
Acute-On-Chronic Liver Failure;
Inflammation;
Therapeutics;
Prognosis
- From:
Journal of Clinical Hepatology
2022;38(8):1927-1930
- CountryChina
- Language:Chinese
-
Abstract:
Acute-on-chronic liver failure (ACLF) is a clinical syndrome with rapid deterioration of liver function caused by a series of predisposing factors on the basis of chronic liver diseases, and it is characterized by multiple organ failure and high short-term mortality. The onset of systemic inflammation is one of the important influencing factors for the progression of ACLF and is the body's natural defense against infection; however, the excessive release of inflammatory mediators breaks the original dynamic balance between "pro-inflammation" and "anti-inflammation", which may aggravate liver function impairment and even lead to decompensation. Therefore, the intensity of inflammatory response is closely associated with the prognosis of patients with ACLF, while at present, not enough attention has been paid to the impact of inflammatory response on patients with ACLF and the measures to deal with cytokine storm. Therefore, this article summarizes the impact of inflammatory response on ACLF and related advances in treatment, so as to provide ideas for the diagnosis and treatment of ACLF in clinical practice.
